New York, April 28, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “North America and Europe Skin Cancer Diagnostics Market Forecast to 2028 – COVID-19 Impact and Analysis – by Type, Screening Type” – https://www.reportlinker.com/p06270023/?utm_source=GNW
The report highlights trends prevailing in the market and factors driving its growth.The market’s growth is attributed to the increasing incidence of skin cancer and launch of new products.
However, the barriers to early skin cancer diagnostics in low and middle-income countries hampers the market growth.
Skin cancer means abnormal growth of skin cells.It develops in the areas exposed to the sun.
Ultraviolet radiation changes the genetic material (DNA) in cells and is the leading cause of skin cancer.Skin cancer is the most common form of cancer.
There are two main categories of skin cancer such as melanoma and non-melanoma.Various imaging solutions such as CT scans, MRIs, PET scans, bone scans, and chest X-rays are used to diagnose skin cancer.
The skin cancer diagnostics market also includes various diagnostics and therapies related to skin cancer, such as chemotherapy, targeted therapy, immunotherapy, radiotherapy, freezing treatment, and scraping therapy that helps cure skin cancer.
The surge in awareness is primarily attributed to the support provided by various governments through awareness and prevention campaigns.The Centers for Disease Control and Prevention (CDC) and its partners conduct monitoring of skin cancer cases, their research, provide education, and interventions for skin cancer.
The monitoring is achieved through national surveys—such as the Youth Risk Behavior Surveillance System and National Health Interview Survey.These surveys assist in assessing the prevalence of sunburn and sun-protective behaviors to help prevent skin cancer.
Countries such as the UK and the Netherlands have also taken initiatives for promoting the early diagnosis of skin cancer.In 2007, the…